Loading…

Octapharma announced plans to build its first US manufacturing site in Rock Hill, South Carolina, a $1.5 billion project expected to create 1,500 jobs. The facility will produce plasma-derived therapies and trauma care products.
“Octapharma...has formally announced plans to establish its first-ever United States-based manufacturing and production site at the Palmetto Research Park in Rock Hill, South Carolina.”prnewswire.com
Summarized from public sources; check the original articles before acting on it.